S-Tab is a platform based on Mannitol and SiMCC formulated to optimize tablet production for improved flow, compressibility, versatility and production speed.
S-Tab ™
Crospovidone, Sodium stearyl fumarate, Sodium starch glycolate, Silicon dioxide, Microcrystalline Cellulose, Silicified MCC, and SPI Pharma's innovative Mannogem XL mannitol
Supplier: SPI Pharma
Product Applications: DC Tablet,
Product Class: Excipient, Pre-formulated Platform,
Product Category: Pharmaceutical
Supplier: SPI Pharma
Product Applications: DC Tablet,
Product Class: Excipient, Pre-formulated Platform,
Product Category: Pharmaceutical
S-Tab ™
$0.00
Product Information
SPI Pharma stands out as a leader in swallow tablet formulations, and they have achieved another optimized platform that incorporates a combination of different materials, including Crospovidone, Sodium stearyl fumarate, Sodium starch glycolate, Silicon dioxide, Microcrystalline Cellulose, Silicified MCC, and SPI Pharma’s innovative Mannogem XL mannitol. The combination of these top-grade materials:
- Allows customer to have a pre-formulated starting point that has excellent tableting performance, with only the API added and a minimum of other excipients to be added
- More versatile and superior overall performance versus competitive “all in one” systems
- Offers superior capabilities to enhance production rates, improve tablet properties, and expedite project development
Advantages
Highly Flowable: Experience unparalleled fluidity in your tablet manufacturing process.
Highly Compressible: Achieve superior tablet compression for enhanced end-product quality.
Versatile for Stability-Sensitive APIs: S-Tab™ is adaptable, making it an ideal choice for formulations containing stability-sensitive APIs.
Efficient High-Speed Direct Compression: Boost your production rates with S-Tab™, optimizing efficiency like never before.
Formulation Advantages
S-Tab is a platform formulated to optimize tablet production
- Based on Mannitol and SiMCC
- Composed entirely of compendial excipients
- No crospovidone, copovidone or povidone
- Provides broad stability protection
- Lactose-free
- Creates robust tablets
- Flows easily
Minimize Stability Risk
- 96% Inert Componentes
- No Crospovidone (Peroxide)
- Non-reactive components with Amines –Secondary/Tertiary
